Amendment in Export Policy of Hydroxychloroquine API and its Formulations

(To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

'

Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Udyog Bhawan New Delhi

Notification No. 13/2015-2020 New Delhi, Dated: 18th June, 2020

Subject: - Amendment in Export Policy of Hydroxychloroquine API and its Formulations.

S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendments in the Notification No. 54 dated 25.03.2020 amending the Schedule 2 of the ITCHS Export Policy related to export of Hydroxychloroquine and its formulations, with immediate effect:

==> picture [484 x 219] intentionally omitted <==

----- Start of picture text -----<br> | |<br>207 E 29334900 ) pa | |<br>39333990 Hydroxychloroquine Prohibited ie |<br>29339900 :<br>207 F 30049059 Formulations made from a ; |<br>|<br>i<br>ee 30049099 ewan | Free |<br>The Notification No. 54 dated 25.03.2020 has been amended to change the export policy of<br>Hydroxychloroquine API and its formulations from “Prohibited” to “Free”, with immediate<br>effect. Paneer<br>----- End of picture text -----<br>

(Amit Yadav) Director General of Foreign Trade Ex-Officio Additional Secretary, Government of[India] E-mail: dgft@nic.in

(Issued from file No. 01/91/180/21/AM20/EC/E-21154)